Rein Therapeutics Capital Expenditures (CapEx) Growth & History (RNTX)
Rein Therapeutics's capital expenditures (capex) was $157,000 for fiscal 2021.
View full Rein Therapeutics company overviewRein Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | $157,000 | $152,000 | +3040.00% |
| 2020 | 2020-12-31 | $5,000 | −$146,000 | −96.69% |
| 2019 | 2019-12-31 | $151,000 | −$4.3M | −96.59% |
| 2018 | 2018-12-31 | $4.4M | $4.3M | +3014.79% |
| 2017 | 2017-12-31 | $142,000 | — | — |
| 2015 | 2015-12-31 | $94,000 | — | — |
Rein Therapeutics quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2021 | 2021-12-31 | $0 | — | — |
| Q3 2021 | 2021-09-30 | $5,000 | $5,000 | — |
| Q2 2021 | 2021-06-30 | $67,000 | — | — |
| Q1 2021 | 2021-03-31 | $85,000 | — | — |
| Q3 2020 | 2020-09-30 | $0 | −$5,000 | — |
| Q4 2019 | 2019-12-31 | $15,000 | −$1.9M | −99.22% |
| Q3 2019 | 2019-09-30 | $5,000 | −$2.3M | −99.78% |
| Q2 2019 | 2019-06-30 | $4,000 | −$202,000 | −98.06% |
| Q1 2019 | 2019-03-31 | $127,000 | $120,000 | +1714.29% |
| Q4 2018 | 2018-12-31 | $1.9M | $1.9M | +2741.18% |
| Q3 2018 | 2018-09-30 | $2.3M | $2.3M | +8337.04% |
| Q2 2018 | 2018-06-30 | $206,000 | $197,000 | +2188.89% |
| Q1 2018 | 2018-03-31 | $7,000 | −$31,000 | −81.58% |
| Q4 2017 | 2017-12-31 | $68,000 | — | — |
| Q3 2017 | 2017-09-30 | $27,000 | — | — |
| Q2 2017 | 2017-06-30 | $9,000 | — | — |
| Q1 2017 | 2017-03-31 | $38,000 | — | — |
Rein Therapeutics capital expenditures (capex) trends
Between the periods ended 2015-12-31 and 2021-12-31, Rein Therapeutics's capital expenditures (capex) increased from $94,000 to $157,000, a change of $63,000. The latest reported quarter, Q4 2021, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rein Therapeutics source filings ↗